Demonstrates FLASH beam irradiation effects in preclinical settings, highlighting potential for reduced tissue damage.
FLASH radiation therapy reduced radiation-induced damage to normal tissue, compared to conventional radiation therapy, and active studies have been undertaken worldwide. While a number of preclinical studies have revealed the effectiveness of this novel radiotherapy, the biological effects have not been fully elucidated. Here, we implemented ultra-high dose-rate FLASH beam irradiation through machine modifications of the core components of an existing clinical linear accelerator, to build a database containing information related to the biological effects of the FLASH beam. We established a protocol that enables a quick conversion between the CONV and FLASH modes of an existing clinical linear accelerator. At 100 cm source-to-surface distance in 10 cm × 10 cm applicator conditions, we achieved FLASH electron beam irradiation characterized by 9.49 MeV mean energy, effective field size (95% iso-dose distribution) ∅ 39.9 mm, and maximum dose rate of 339.1 Gy/s. Irradiation of an elliptical Gaussian beam with flatness of 12.7% and symmetry of 0.3% was confirmed. Furthermore, most of the required preclinical conditions were satisfied. However, although the pulse dose value obtained from the protocol is expected to meet the requirement of 1 Gy/pulse, this result was not confirmed in this study, and further investigation is required.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: